The API-excipient compatibility analysis provided by CD Formulation can provide effective data for the selection and determination of formulation excipients and formulation technology for drug ...
As a service provider for custom pharmaceutical formulation projects, CD Formulation announces today that it is able to conduct API-excipient compatibility analysis service for clients across the ...
Applying a QbD approach helps address excipient variability and other quality features. A quality-by-design (QbD) approach to drug product development and manufacturing ensures that quality is ...
In the complex realm of pharmaceuticals, two crucial elements play a pivotal role in the formulation of effective and safe medications: Active Pharmaceutical Ingredients (APIs) and excipients. These ...
Experts review considerations for selecting excipients for solid-dosage drug performance and manufacturability. Oral formulations, which form the largest category of pharmaceutical dosage forms, tend ...
WILMINGTON, Del., July 9, 2019 /PRNewswire/ -- Noramco and SPI Pharma announced that they have completed work on an excipient compatibility study examining a range of options for the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results